Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-520-2 | CAS number: 18718-07-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
BASIC SUMMARY OF TOXICOKINETICS: MANGANESE BIS(DIHYDROGEN PHOSPHATE)
Absorption, metabolism and distribution
Manganese is an essential element that is found in most diets. In humans, manganese is homeostatically regulated to maintain stable tissue levels of manganese through the regulation of gastrointestinal absorption and hepatobiliary excretion. In addition, manganese is a normal component of human and animal tissues and fluids.
The solubility of manganese bis(dihydrogen phosphate) has been found to be 630 g/l of solution at 20.0 ± 0.5°C in un-buffered glass double-distilled water, resulting in sample solution pH’s of approximately 1.7 to 2.1 (Bulter R, 2010) and therefore the material is considered to be very soluble. As such, the manganese is expected to be readily bioavailable after oral administration.
Several factors are known to influence the oral uptake of soluble manganese substances, including iron status, dietary matrix, fasting status and existing body burden of manganese. The LD50 of manganese bis(dihydrogen phosphate) has been determined to be >2,000 mg/kg bw (Bradshaw J, 2012) and therefore it can be considered that the material has a low potential for toxicity via the oral route. The majority of any test material that is ingested orally is likely to pass through the GI tract unchanged and be excreted in the faeces as absorption across the gastrointestinal tract in humans is considered to average between 3-5%,1 thus further supporting the conclusion that the test material has a small potential for absorption by oral ingestion.
The test material is not a considered to be a skin irritant (Warren N, 2013) and absorption via the dermal route is considered to be unfavourable as manganese is not considered to penetrate the skin readily.
Particle size analysis of a sample manganese bis(dihydrogen phosphate) powder showed that less than 2% of the particles were greater than 100 µm diameter. As such manganese bis(dihydrogen phosphate) has a low potential to be inhaled and respired due to its particle size distribution, however in situations where the material may be ground or processed inhalation could occur. Tissue manganese concentrations following inhalation exposure of various inorganic forms of manganese have been extensively studied. It has been reported that inhalation exposure to soluble forms of manganese results in higher brain manganese concentrations than those achieved following exposure to an insoluble form of manganese.
Much research has been performed to investigate the effects of inhalation of manganese substances and it has been concluded that soluble inorganic Mn2+ containing substances are likely to result in neurotoxicity when inhaled. Fine powders (MMAD ca. 2μm), can be absorbed and widely distributed throughout the body, including the brain.
Excretion
In humans, absorbed manganese is removed from the blood by the liver where it conjugates with bile and is excreted into the intestine. Biliary secretion is the main pathway by which manganese reaches the intestines where most of the element is excreted in the faeces. However, some of the manganese in the intestine is reabsorbed through enterohepatic circulation.1
1. TOXICOLOGICAL PROFILE FOR MANGANESE. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Public Health Service Agency for Toxic Substances and Disease Registry. September 2012
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
